Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Judit Pich Martínez
This is a population-based study. Subjects will attend a primary care center where a physical examination, general blood test and transient elastography will be carried out. Only the group of patients with high-risk for liver fibrosis will be evaluated in a second visit at the University Hospital.
Age
40–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age ≥ 40 years
Able to give informed consent
You may not be if
Previously known chronic liver disease (including cholestasis). Patients with already known liver steatosis but no diagnosis of liver fibrosis or cirrhosis can be included
Subjects with mental incapacity, language barrier, insufficient social support or any other reason considered by the investigator precluding adequate understanding or cooperation in the study
Subjects with a history of current malignancy including solid tumors and hematologic disorders
Subjects with significant extrahepatic disease that may impair short-term prognosis (including congestive heart failure New York Heart Association Grade IV, COPD GOLD \>3)
Subjects with kidney disease (serum creatinine \>3mg/dL or under renal replacement therapy)
Clareo Health | Population-based Study in Screening for Liver Fibrosis
